Nilofar N. Mohamedmohaideen

574 total citations
6 papers, 489 citations indexed

About

Nilofar N. Mohamedmohaideen is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, Nilofar N. Mohamedmohaideen has authored 6 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Physiology and 2 papers in Oncology. Recurrent topics in Nilofar N. Mohamedmohaideen's work include Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers), Alzheimer's disease research and treatments (4 papers) and Biochemical and Molecular Research (1 paper). Nilofar N. Mohamedmohaideen is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers), Alzheimer's disease research and treatments (4 papers) and Biochemical and Molecular Research (1 paper). Nilofar N. Mohamedmohaideen collaborates with scholars based in United States and Italy. Nilofar N. Mohamedmohaideen's co-authors include S.K. Palaninathan, James C. Sacchettini, Jeffery W. Kelly, Hans E. Purkey, Kyle P. Chiang, Songpon Deechongkit, R. Luke Wiseman, Hossein Razavi, Evan T. Powers and H. Michael Petrassi and has published in prestigious journals such as Angewandte Chemie International Edition, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Nilofar N. Mohamedmohaideen

6 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nilofar N. Mohamedmohaideen United States 6 300 145 104 81 79 6 489
Diane Allegro France 15 298 1.0× 242 1.7× 43 0.4× 91 1.1× 76 1.0× 25 543
Subhasish Tapadar United States 16 469 1.6× 300 2.1× 23 0.2× 42 0.5× 120 1.5× 25 689
Mohammed K. Abdel‐Hamid Egypt 12 225 0.8× 191 1.3× 20 0.2× 73 0.9× 38 0.5× 14 402
Amit Ketkar United States 17 432 1.4× 127 0.9× 20 0.2× 24 0.3× 60 0.8× 30 603
Małgorzata Bobrowska-Hägerstrand Finland 14 281 0.9× 77 0.5× 107 1.0× 33 0.4× 78 1.0× 30 434
Helen Browne United Kingdom 6 351 1.2× 349 2.4× 26 0.3× 76 0.9× 62 0.8× 8 742
Thai Nguyen United States 6 108 0.4× 261 1.8× 25 0.2× 49 0.6× 63 0.8× 7 373
Torsten Merbitz-Zahradnik Germany 10 434 1.4× 48 0.3× 19 0.2× 41 0.5× 47 0.6× 10 611
Camille Decroocq France 11 467 1.6× 547 3.8× 105 1.0× 31 0.4× 25 0.3× 11 662
Soko Kasai Japan 12 242 0.8× 110 0.8× 135 1.3× 17 0.2× 49 0.6× 22 497

Countries citing papers authored by Nilofar N. Mohamedmohaideen

Since Specialization
Citations

This map shows the geographic impact of Nilofar N. Mohamedmohaideen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nilofar N. Mohamedmohaideen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nilofar N. Mohamedmohaideen more than expected).

Fields of papers citing papers by Nilofar N. Mohamedmohaideen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nilofar N. Mohamedmohaideen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nilofar N. Mohamedmohaideen. The network helps show where Nilofar N. Mohamedmohaideen may publish in the future.

Co-authorship network of co-authors of Nilofar N. Mohamedmohaideen

This figure shows the co-authorship network connecting the top 25 collaborators of Nilofar N. Mohamedmohaideen. A scholar is included among the top collaborators of Nilofar N. Mohamedmohaideen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nilofar N. Mohamedmohaideen. Nilofar N. Mohamedmohaideen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Palaninathan, S.K., Nilofar N. Mohamedmohaideen, Elisabetta Orlandini, et al.. (2009). Novel Transthyretin Amyloid Fibril Formation Inhibitors: Synthesis, Biological Evaluation, and X-Ray Structural Analysis. PLoS ONE. 4(7). e6290–e6290. 48 indexed citations
2.
Mohamedmohaideen, Nilofar N., S.K. Palaninathan, P Morin, et al.. (2008). Structure and Function of the Virulence-Associated High-Temperature Requirement A of Mycobacterium tuberculosis. Biochemistry. 47(23). 6092–6102. 53 indexed citations
3.
Palaninathan, S.K., et al.. (2008). Structural Insight into pH-Induced Conformational Changes within the Native Human Transthyretin Tetramer. Journal of Molecular Biology. 382(5). 1157–1167. 63 indexed citations
4.
Johnson, Steven M., H. Michael Petrassi, S.K. Palaninathan, et al.. (2005). Bisaryloxime Ethers as Potent Inhibitors of Transthyretin Amyloid Fibril Formation. Journal of Medicinal Chemistry. 48(5). 1576–1587. 88 indexed citations
5.
Razavi, Hossein, S.K. Palaninathan, Evan T. Powers, et al.. (2003). Benzoxazoles as Transthyretin Amyloid Fibril Inhibitors: Synthesis, Evaluation, and Mechanism of Action. Angewandte Chemie International Edition. 42(24). 2758–2761. 200 indexed citations
6.
Razavi, Hossein, S.K. Palaninathan, Evan T. Powers, et al.. (2003). Benzoxazoles as Transthyretin Amyloid Fibril Inhibitors: Synthesis, Evaluation, and Mechanism of Action. Angewandte Chemie. 115(24). 2864–2867. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026